Bone Marrow Transplant-North America Market Status and Trend Report 2013-2023
Report Summary
Bone Marrow Transplant-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Bone Marrow Transplant industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Bone Marrow Transplant 2013-2017, and development forecast 2018-2023
Main market players of Bone Marrow Transplant in North America, with company and product introduction, position in the Bone Marrow Transplant market
Market status and development trend of Bone Marrow Transplant by types and applications
Cost and profit status of Bone Marrow Transplant, and marketing status
Market growth drivers and challenges
The report segments the North America Bone Marrow Transplant market as:
North America Bone Marrow Transplant Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Bone Marrow Transplant Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Autologous Hematopoietic Stem Cell Transplantation
Syngeneic Hematopoietic Stem Cell Transplantation
Allo-HSCT
North America Bone Marrow Transplant Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Acute Leukemia
Chronic Leukemia
North America Bone Marrow Transplant Market: Players Segment Analysis (Company and Product introduction, Bone Marrow Transplant Sales Volume, Revenue, Price and Gross Margin):
AllCells (USA)
Lonza (Switzerland)
Merck (USA)
Sanofi (France)
Translational Biosciences (USA)
Athersys (USA)
Beike Biotechnology (China)
BioTime (USA)
Bluebird Bio (USA)
Caladrius (USA)
Cellular Biomedicine Group (USA)
Cesca Therapeutics (USA)
TiGenix (Belgium)
CHA Biotech (Korea)
Chugai Pharmaceutical (UK)
CORESTEM (Korea)
Gamida Cell (USA)
Histocell (Spain)
Hemostemix (Canada)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Bone Marrow Transplant-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Bone Marrow Transplant industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Bone Marrow Transplant 2013-2017, and development forecast 2018-2023
Main market players of Bone Marrow Transplant in North America, with company and product introduction, position in the Bone Marrow Transplant market
Market status and development trend of Bone Marrow Transplant by types and applications
Cost and profit status of Bone Marrow Transplant, and marketing status
Market growth drivers and challenges
The report segments the North America Bone Marrow Transplant market as:
North America Bone Marrow Transplant Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Bone Marrow Transplant Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Autologous Hematopoietic Stem Cell Transplantation
Syngeneic Hematopoietic Stem Cell Transplantation
Allo-HSCT
North America Bone Marrow Transplant Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Acute Leukemia
Chronic Leukemia
North America Bone Marrow Transplant Market: Players Segment Analysis (Company and Product introduction, Bone Marrow Transplant Sales Volume, Revenue, Price and Gross Margin):
AllCells (USA)
Lonza (Switzerland)
Merck (USA)
Sanofi (France)
Translational Biosciences (USA)
Athersys (USA)
Beike Biotechnology (China)
BioTime (USA)
Bluebird Bio (USA)
Caladrius (USA)
Cellular Biomedicine Group (USA)
Cesca Therapeutics (USA)
TiGenix (Belgium)
CHA Biotech (Korea)
Chugai Pharmaceutical (UK)
CORESTEM (Korea)
Gamida Cell (USA)
Histocell (Spain)
Hemostemix (Canada)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BONE MARROW TRANSPLANT
1.1 Definition of Bone Marrow Transplant in This Report
1.2 Commercial Types of Bone Marrow Transplant
1.2.1 Autologous Hematopoietic Stem Cell Transplantation
1.2.2 Syngeneic Hematopoietic Stem Cell Transplantation
1.2.3 Allo-HSCT
1.3 Downstream Application of Bone Marrow Transplant
1.3.1 Acute Leukemia
1.3.2 Chronic Leukemia
1.4 Development History of Bone Marrow Transplant
1.5 Market Status and Trend of Bone Marrow Transplant 2013-2023
1.5.1 North America Bone Marrow Transplant Market Status and Trend 2013-2023
1.5.2 Regional Bone Marrow Transplant Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Bone Marrow Transplant in North America 2013-2017
2.2 Consumption Market of Bone Marrow Transplant in North America by Regions
2.2.1 Consumption Volume of Bone Marrow Transplant in North America by Regions
2.2.2 Revenue of Bone Marrow Transplant in North America by Regions
2.3 Market Analysis of Bone Marrow Transplant in North America by Regions
2.3.1 Market Analysis of Bone Marrow Transplant in United States 2013-2017
2.3.2 Market Analysis of Bone Marrow Transplant in Canada 2013-2017
2.3.3 Market Analysis of Bone Marrow Transplant in Mexico 2013-2017
2.4 Market Development Forecast of Bone Marrow Transplant in North America 2018-2023
2.4.1 Market Development Forecast of Bone Marrow Transplant in North America 2018-2023
2.4.2 Market Development Forecast of Bone Marrow Transplant by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Bone Marrow Transplant in North America by Types
3.1.2 Revenue of Bone Marrow Transplant in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Bone Marrow Transplant in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Bone Marrow Transplant in North America by Downstream Industry
4.2 Demand Volume of Bone Marrow Transplant by Downstream Industry in Major Countries
4.2.1 Demand Volume of Bone Marrow Transplant by Downstream Industry in United States
4.2.2 Demand Volume of Bone Marrow Transplant by Downstream Industry in Canada
4.2.3 Demand Volume of Bone Marrow Transplant by Downstream Industry in Mexico
4.3 Market Forecast of Bone Marrow Transplant in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BONE MARROW TRANSPLANT
5.1 North America Economy Situation and Trend Overview
5.2 Bone Marrow Transplant Downstream Industry Situation and Trend Overview
CHAPTER 6 BONE MARROW TRANSPLANT MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Bone Marrow Transplant in North America by Major Players
6.2 Revenue of Bone Marrow Transplant in North America by Major Players
6.3 Basic Information of Bone Marrow Transplant by Major Players
6.3.1 Headquarters Location and Established Time of Bone Marrow Transplant Major Players
6.3.2 Employees and Revenue Level of Bone Marrow Transplant Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BONE MARROW TRANSPLANT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 AllCells (USA)
7.1.1 Company profile
7.1.2 Representative Bone Marrow Transplant Product
7.1.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of AllCells (USA)
7.2 Lonza (Switzerland)
7.2.1 Company profile
7.2.2 Representative Bone Marrow Transplant Product
7.2.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Lonza (Switzerland)
7.3 Merck (USA)
7.3.1 Company profile
7.3.2 Representative Bone Marrow Transplant Product
7.3.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Merck (USA)
7.4 Sanofi (France)
7.4.1 Company profile
7.4.2 Representative Bone Marrow Transplant Product
7.4.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Sanofi (France)
7.5 Translational Biosciences (USA)
7.5.1 Company profile
7.5.2 Representative Bone Marrow Transplant Product
7.5.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Translational Biosciences (USA)
7.6 Athersys (USA)
7.6.1 Company profile
7.6.2 Representative Bone Marrow Transplant Product
7.6.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Athersys (USA)
7.7 Beike Biotechnology (China)
7.7.1 Company profile
7.7.2 Representative Bone Marrow Transplant Product
7.7.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Beike Biotechnology (China)
7.8 BioTime (USA)
7.8.1 Company profile
7.8.2 Representative Bone Marrow Transplant Product
7.8.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of BioTime (USA)
7.9 Bluebird Bio (USA)
7.9.1 Company profile
7.9.2 Representative Bone Marrow Transplant Product
7.9.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Bluebird Bio (USA)
7.10 Caladrius (USA)
7.10.1 Company profile
7.10.2 Representative Bone Marrow Transplant Product
7.10.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Caladrius (USA)
7.11 Cellular Biomedicine Group (USA)
7.11.1 Company profile
7.11.2 Representative Bone Marrow Transplant Product
7.11.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Cellular Biomedicine Group (USA)
7.12 Cesca Therapeutics (USA)
7.12.1 Company profile
7.12.2 Representative Bone Marrow Transplant Product
7.12.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Cesca Therapeutics (USA)
7.13 TiGenix (Belgium)
7.13.1 Company profile
7.13.2 Representative Bone Marrow Transplant Product
7.13.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of TiGenix (Belgium)
7.14 CHA Biotech (Korea)
7.14.1 Company profile
7.14.2 Representative Bone Marrow Transplant Product
7.14.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of CHA Biotech (Korea)
7.15 Chugai Pharmaceutical (UK)
7.15.1 Company profile
7.15.2 Representative Bone Marrow Transplant Product
7.15.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Chugai Pharmaceutical (UK)
7.16 CORESTEM (Korea)
7.17 Gamida Cell (USA)
7.18 Histocell (Spain)
7.19 Hemostemix (Canada)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BONE MARROW TRANSPLANT
8.1 Industry Chain of Bone Marrow Transplant
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BONE MARROW TRANSPLANT
9.1 Cost Structure Analysis of Bone Marrow Transplant
9.2 Raw Materials Cost Analysis of Bone Marrow Transplant
9.3 Labor Cost Analysis of Bone Marrow Transplant
9.4 Manufacturing Expenses Analysis of Bone Marrow Transplant
CHAPTER 10 MARKETING STATUS ANALYSIS OF BONE MARROW TRANSPLANT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Bone Marrow Transplant in This Report
1.2 Commercial Types of Bone Marrow Transplant
1.2.1 Autologous Hematopoietic Stem Cell Transplantation
1.2.2 Syngeneic Hematopoietic Stem Cell Transplantation
1.2.3 Allo-HSCT
1.3 Downstream Application of Bone Marrow Transplant
1.3.1 Acute Leukemia
1.3.2 Chronic Leukemia
1.4 Development History of Bone Marrow Transplant
1.5 Market Status and Trend of Bone Marrow Transplant 2013-2023
1.5.1 North America Bone Marrow Transplant Market Status and Trend 2013-2023
1.5.2 Regional Bone Marrow Transplant Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Bone Marrow Transplant in North America 2013-2017
2.2 Consumption Market of Bone Marrow Transplant in North America by Regions
2.2.1 Consumption Volume of Bone Marrow Transplant in North America by Regions
2.2.2 Revenue of Bone Marrow Transplant in North America by Regions
2.3 Market Analysis of Bone Marrow Transplant in North America by Regions
2.3.1 Market Analysis of Bone Marrow Transplant in United States 2013-2017
2.3.2 Market Analysis of Bone Marrow Transplant in Canada 2013-2017
2.3.3 Market Analysis of Bone Marrow Transplant in Mexico 2013-2017
2.4 Market Development Forecast of Bone Marrow Transplant in North America 2018-2023
2.4.1 Market Development Forecast of Bone Marrow Transplant in North America 2018-2023
2.4.2 Market Development Forecast of Bone Marrow Transplant by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Bone Marrow Transplant in North America by Types
3.1.2 Revenue of Bone Marrow Transplant in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Bone Marrow Transplant in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Bone Marrow Transplant in North America by Downstream Industry
4.2 Demand Volume of Bone Marrow Transplant by Downstream Industry in Major Countries
4.2.1 Demand Volume of Bone Marrow Transplant by Downstream Industry in United States
4.2.2 Demand Volume of Bone Marrow Transplant by Downstream Industry in Canada
4.2.3 Demand Volume of Bone Marrow Transplant by Downstream Industry in Mexico
4.3 Market Forecast of Bone Marrow Transplant in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BONE MARROW TRANSPLANT
5.1 North America Economy Situation and Trend Overview
5.2 Bone Marrow Transplant Downstream Industry Situation and Trend Overview
CHAPTER 6 BONE MARROW TRANSPLANT MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Bone Marrow Transplant in North America by Major Players
6.2 Revenue of Bone Marrow Transplant in North America by Major Players
6.3 Basic Information of Bone Marrow Transplant by Major Players
6.3.1 Headquarters Location and Established Time of Bone Marrow Transplant Major Players
6.3.2 Employees and Revenue Level of Bone Marrow Transplant Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BONE MARROW TRANSPLANT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 AllCells (USA)
7.1.1 Company profile
7.1.2 Representative Bone Marrow Transplant Product
7.1.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of AllCells (USA)
7.2 Lonza (Switzerland)
7.2.1 Company profile
7.2.2 Representative Bone Marrow Transplant Product
7.2.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Lonza (Switzerland)
7.3 Merck (USA)
7.3.1 Company profile
7.3.2 Representative Bone Marrow Transplant Product
7.3.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Merck (USA)
7.4 Sanofi (France)
7.4.1 Company profile
7.4.2 Representative Bone Marrow Transplant Product
7.4.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Sanofi (France)
7.5 Translational Biosciences (USA)
7.5.1 Company profile
7.5.2 Representative Bone Marrow Transplant Product
7.5.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Translational Biosciences (USA)
7.6 Athersys (USA)
7.6.1 Company profile
7.6.2 Representative Bone Marrow Transplant Product
7.6.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Athersys (USA)
7.7 Beike Biotechnology (China)
7.7.1 Company profile
7.7.2 Representative Bone Marrow Transplant Product
7.7.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Beike Biotechnology (China)
7.8 BioTime (USA)
7.8.1 Company profile
7.8.2 Representative Bone Marrow Transplant Product
7.8.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of BioTime (USA)
7.9 Bluebird Bio (USA)
7.9.1 Company profile
7.9.2 Representative Bone Marrow Transplant Product
7.9.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Bluebird Bio (USA)
7.10 Caladrius (USA)
7.10.1 Company profile
7.10.2 Representative Bone Marrow Transplant Product
7.10.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Caladrius (USA)
7.11 Cellular Biomedicine Group (USA)
7.11.1 Company profile
7.11.2 Representative Bone Marrow Transplant Product
7.11.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Cellular Biomedicine Group (USA)
7.12 Cesca Therapeutics (USA)
7.12.1 Company profile
7.12.2 Representative Bone Marrow Transplant Product
7.12.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Cesca Therapeutics (USA)
7.13 TiGenix (Belgium)
7.13.1 Company profile
7.13.2 Representative Bone Marrow Transplant Product
7.13.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of TiGenix (Belgium)
7.14 CHA Biotech (Korea)
7.14.1 Company profile
7.14.2 Representative Bone Marrow Transplant Product
7.14.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of CHA Biotech (Korea)
7.15 Chugai Pharmaceutical (UK)
7.15.1 Company profile
7.15.2 Representative Bone Marrow Transplant Product
7.15.3 Bone Marrow Transplant Sales, Revenue, Price and Gross Margin of Chugai Pharmaceutical (UK)
7.16 CORESTEM (Korea)
7.17 Gamida Cell (USA)
7.18 Histocell (Spain)
7.19 Hemostemix (Canada)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BONE MARROW TRANSPLANT
8.1 Industry Chain of Bone Marrow Transplant
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BONE MARROW TRANSPLANT
9.1 Cost Structure Analysis of Bone Marrow Transplant
9.2 Raw Materials Cost Analysis of Bone Marrow Transplant
9.3 Labor Cost Analysis of Bone Marrow Transplant
9.4 Manufacturing Expenses Analysis of Bone Marrow Transplant
CHAPTER 10 MARKETING STATUS ANALYSIS OF BONE MARROW TRANSPLANT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
